Internal Medicine, Endocrinology, Diabetes, & Metabolism · Danville, IN
NPI
1255424594
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
100 Hospital Ln, Suite 205
Danville, IN, 46122
Phone (317) 745-7445
Groups this clinician bills Medicare through
Medicare paid, 2024
$353K
25,095 services
Medicare patients, 2024
518
Average age 73
Drug cost, 2024
$4.3M
8,791 prescriptions
Company payments, 2025
$1,396
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Priya P Menon was code J3111 (injection, romosozumab-aqqg, 1 mg), 13,860 times for 15 patients. In total Priya P Menon billed 25,095 services in 15 codes, and Medicare paid $353K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 13,860 | 15 | $8.57 | $119K |
| J0897 Injection, denosumab, 1 mg | Office | 5,040 | 52 | $20.17 | $102K |
| 99214 Office E&M - Established | Office | 844 | 479 | $84.57 | $71K |
| 83036 Blood Count | Office | 541 | 266 | $9.47 | $5,125 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 513 | 386 | $12.31 | $6,313 |
| 95251 Test - Miscellaneous | Office | 329 | 143 | $24.12 | $7,935 |
| 96372 Injection Administration | Office | 231 | 77 | $10.82 | $2,499 |
| 99204 Office E&M - New | Office | 30 | 30 | $118.91 | $3,567 |
By year: 2022 $247K for 16,149 services; 2023 $287K for 19,730 services; 2024 $353K for 25,095 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 541 | 266 | $9.47 | $5,125 |
Medicare prescription drug claims, 2024
In 2024, the drug Priya P Menon prescribed most often to Medicare patients was Atorvastatin Calcium, with 590 prescriptions and refills. In total Priya P Menon wrote 8,791 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 590 | 1,646 | 164 | $4,915 |
| Levothyroxine Sodium Generic | 528 | 1,474 | 143 | $5,615 |
| Ozempic Semaglutide | 461 | 551 | 80 | $522K |
| Ezetimibe Generic | 390 | 1,029 | 108 | $8,227 |
| Mounjaro Tirzepatide | 350 | 414 | 54 | $435K |
| Humalog Kwikpen U-100 Insulin Lispro | 340 | 724 | 107 | $174K |
| Metformin Hcl Generic | 316 | 852 | 82 | $2,017 |
| Jardiance Empagliflozin | 310 | 547 | 57 | $319K |
| Pioglitazone Hcl Generic | 302 | 827 | 88 | $2,851 |
| Rosuvastatin Calcium Generic | 234 | 643 | 66 | $2,619 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 222 | 572 | 76 | $39K |
| Synthroid Levothyroxine Sodium | 212 | 497 | 51 | $18K |
| Metformin Hcl Er Metformin Hcl | 207 | 599 | 68 | $1,639 |
| Novolog Flexpen Insulin Aspart | 194 | 386 | 60 | $91K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 192 | 441 | 78 | $23K |
Brand drugs: 3,634 claims; generic drugs: 4,645 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Priya P Menon $1,396 ($1,396 in general payments such as food, travel and fees) from 25 companies. The largest payer was Amgen Inc. with $296.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 26 | $296 |
| Lilly USA, LLC LLY | 11 | $159 |
| Xeris Pharmaceuticals, Inc. | 6 | $102 |
| Novo Nordisk Inc NVO | 4 | $74.87 |
| Beta Bionics, Inc. BBNX | 3 | $71.66 |
| Amneal Pharmaceuticals LLC AMRX | 4 | $66.66 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $66.65 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $57.63 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $55.34 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $45.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.